These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 27379929)
1. KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL. Zhu L; Xiao F; Yu Y; Wang H; Fang M; Yang Y; Sun H; Wang L; Sheng Y Anticancer Drugs; 2016 Oct; 27(9):863-72. PubMed ID: 27379929 [TBL] [Abstract][Full Text] [Related]
2. Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells. Yin Y; Sun H; Xu J; Xiao F; Wang H; Yang Y; Ren H; Wu CT; Gao C; Wang L Leuk Lymphoma; 2015 Jun; 56(6):1813-20. PubMed ID: 25146433 [TBL] [Abstract][Full Text] [Related]
3. KSP inhibitor SB743921 induces death of multiple myeloma cells via inhibition of the NF-κB signaling pathway. Song IS; Jeong YJ; Nyamaa B; Jeong SH; Kim HK; Kim N; Ko KS; Rhee BD; Han J BMB Rep; 2015 Oct; 48(10):571-6. PubMed ID: 25772758 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells. Carter BZ; Mak DH; Woessner R; Gross S; Schober WD; Estrov Z; Kantarjian H; Andreeff M Leukemia; 2009 Oct; 23(10):1755-62. PubMed ID: 19458629 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of Kinesin spindle protein inhibits proliferation, induces apoptosis and increases chemosensitivity in hepatocellular carcinoma cells. Doan CC; Doan NT; Nguyen QH; Nguyen MH; Do MS; Le VD Iran Biomed J; 2015; 19(1):1-16. PubMed ID: 25605484 [TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598 [TBL] [Abstract][Full Text] [Related]
7. Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway. Ferreira AK; Meneguelo R; Pereira A; Filho OM; Chierice GO; Maria DA Biomed Pharmacother; 2013 Jul; 67(6):481-7. PubMed ID: 23773853 [TBL] [Abstract][Full Text] [Related]
8. The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma. Bongero D; Paoluzzi L; Marchi E; Zullo KM; Neisa R; Mao Y; Escandon R; Wood K; O'Connor OA Leuk Lymphoma; 2015; 56(10):2945-52. PubMed ID: 25860245 [TBL] [Abstract][Full Text] [Related]
9. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway. Huang KF; Zhang GD; Huang YQ; Diao Y Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776 [TBL] [Abstract][Full Text] [Related]
10. 2-Methylpyridine-1-ium-1-sulfonate from Allium hirtifolium: An anti-angiogenic compound which inhibits growth of MCF-7 and MDA-MB-231 cells through cell cycle arrest and apoptosis induction. Mohammadi-Motlagh HR; Shokohinia Y; Mojarrab M; Rasouli H; Mostafaie A Biomed Pharmacother; 2017 Sep; 93():117-129. PubMed ID: 28624423 [TBL] [Abstract][Full Text] [Related]
11. Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor cells treated with the kinesin spindle protein inhibitor ARRY-520. Tunquist BJ; Woessner RD; Walker DH Mol Cancer Ther; 2010 Jul; 9(7):2046-56. PubMed ID: 20571074 [TBL] [Abstract][Full Text] [Related]
12. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. Majumder B; Wahle KW; Moir S; Schofield A; Choe SN; Farquharson A; Grant I; Heys SD FASEB J; 2002 Sep; 16(11):1447-9. PubMed ID: 12205043 [TBL] [Abstract][Full Text] [Related]
13. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells. Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of inhibition of human KSP by ispinesib. Lad L; Luo L; Carson JD; Wood KW; Hartman JJ; Copeland RA; Sakowicz R Biochemistry; 2008 Mar; 47(11):3576-85. PubMed ID: 18290633 [TBL] [Abstract][Full Text] [Related]
15. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo. Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383 [TBL] [Abstract][Full Text] [Related]
16. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
17. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis. Tao W; South VJ; Diehl RE; Davide JP; Sepp-Lorenzino L; Fraley ME; Arrington KL; Lobell RB Mol Cell Biol; 2007 Jan; 27(2):689-98. PubMed ID: 17101792 [TBL] [Abstract][Full Text] [Related]
18. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function. Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313 [TBL] [Abstract][Full Text] [Related]
19. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells. Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697 [TBL] [Abstract][Full Text] [Related]
20. Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding. Park EY; Woo Y; Kim SJ; Kim DH; Lee EK; De U; Kim KS; Lee J; Jung JH; Ha KT; Choi WS; Kim IS; Lee BM; Yoon S; Moon HR; Kim HS Int J Biol Sci; 2016; 12(12):1555-1567. PubMed ID: 27994519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]